These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Characterization of a soluble suppressor of human B cell immunoglobulin biosynthesis produced by a continuous human suppressor T cell line. Fleisher TA; Greene WC; Uchiyama T; Goldman CK; Nelson DL; Blaese RM; Waldmann TA J Exp Med; 1981 Jul; 154(1):156-67. PubMed ID: 6454754 [TBL] [Abstract][Full Text] [Related]
45. Augmentation of macrophage complement receptor function in vitro. IV. The lymphokine that activates macrophage C3 receptors for phagocytosis binds to a fucose-bearing glycoprotein on the macrophage plasma membrane. Griffin FM; Mullinax PJ J Exp Med; 1984 Oct; 160(4):1206-18. PubMed ID: 6384418 [TBL] [Abstract][Full Text] [Related]
47. The regulation of tissue eosinophilia. III. In vitro production of eosinophil-directed chemotactic inhibitory factor by T lymphocytes of complete Freund's adjuvant-treated guinea-pigs. Tashiro K; Sakata K; Hirashima M; Hayashi H Immunology; 1985 May; 55(1):115-24. PubMed ID: 3873403 [TBL] [Abstract][Full Text] [Related]
48. Analysis of sugar-binding sites in mammalian cell nuclei by quantitative flow microfluorometry. Sève AP; Hubert J; Bouvier D; Bourgeois C; Midoux P; Roche AC; Monsigny M Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5997-6001. PubMed ID: 3461474 [TBL] [Abstract][Full Text] [Related]
49. Potentiation of neutrophil aggregation by human leukocyte inhibitory factor. Schainberg H; Borish L; Rocklin RE Inflammation; 1988 Jun; 12(3):203-11. PubMed ID: 2843462 [TBL] [Abstract][Full Text] [Related]
50. Role of monocyte fucose-receptors in T-cell fibronectin activity. Donson J; Mandy K; Feng ZH; Mandy S; Brown EJ; Godfrey HP Immunology; 1991 Nov; 74(3):473-7. PubMed ID: 1769694 [TBL] [Abstract][Full Text] [Related]
51. The effect of PHA-activated MN-cell supernatants on polymorphonuclear leucocyte function. Lomnitzer R; Glover A; Rabson AR Clin Exp Immunol; 1977 Sep; 29(3):501-8. PubMed ID: 589867 [TBL] [Abstract][Full Text] [Related]
52. The role of cell-mediated immunity in the induction of inflammatory responses. Parke-Davis Award Lecture, 1977. Cohen S Am J Pathol; 1977 Sep; 88(3):502-28. PubMed ID: 329682 [TBL] [Abstract][Full Text] [Related]
53. Requirement for alpha-L-fucose on the macrophage membrane receptor for MIF. Remold HG J Exp Med; 1973 Nov; 138(5):1065-76. PubMed ID: 4583070 [TBL] [Abstract][Full Text] [Related]
54. Polyclonal B cell activation by a B cell differentiation factor, B151-TRF2. II. Evidence for interaction of B151-TRF2 with glycoprotein on B cell membrane via recognition of terminal N-acetyl-D-glucosamine residue(s). Katoh Y; Ono S; Takahama Y; Miyake K; Hamaoka T J Immunol; 1986 Nov; 137(9):2871-7. PubMed ID: 3489778 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of human natural killer activity by 2-deoxy-D-glucose and other sugars. Schlesinger M; Bekesi JG J Clin Lab Immunol; 1984 Sep; 15(1):19-26. PubMed ID: 6512844 [TBL] [Abstract][Full Text] [Related]
56. Specific binding of leukocyte inhibitory factor to neutrophil plasma membranes. Klempner MS; Rocklin RE J Immunol; 1982 May; 128(5):2040-3. PubMed ID: 7037959 [TBL] [Abstract][Full Text] [Related]
57. Role of monosaccharides in the interaction of two lymphocyte mediators with their target cells. Rocklin RE J Immunol; 1976 Mar; 116(3):816-20. PubMed ID: 768376 [TBL] [Abstract][Full Text] [Related]